Galapagos NV's IPO

Galapagos NV raised a round of funding on May 01, 2005. Investors include Public.

Galapagos is a clinical stage biotech company focused on developing novel medicines. Galapagos' most advanced candidate drug GLPG0634 shows excellent safety and efficacy in rheumatoid arthritis patien…

Articles about Galapagos NV's IPO: